| Literature DB >> 34096383 |
Tiziana Ciarambino1, Ombretta Para2, Mauro Giordano3.
Abstract
In COVID-19 disease, are reported gender differences in relation to severity and death. The aim of this review is to highlight gender differences in the immune response to COVID-19. The included studies were identified using PubMed, until 30 October 2020. The search included the following keywords: SARS-CoV-2, COVID-19, gender, age, sex, and immune system. Literature described that females compared to males have greater inflammatory, antiviral, and humoral immune responses. In female, estrogen is a potential ally to alleviate SARS-COV-2 disease. In male, testosterone reduces vaccination response and depresses the cytokine response. In the older patients, and in particular, in female older patients, it has been reported a progressive functional decline in the immune systems. Differences by gender were reported in infection diseases, including SARS-CoV-2. These data should be confirmed by the other epidemiological studies.Entities:
Keywords: COVID-19; SARS-CoV-2; age; aging; gender; immune system; sex; vaccine
Year: 2021 PMID: 34096383 DOI: 10.1177/17455065211022262
Source DB: PubMed Journal: Womens Health (Lond) ISSN: 1745-5057